Join 23,000+ pharma and biotech leaders. No vendor content. No credit card.
Experience the power of leveraging the knowledge and experience of your peers while enjoying curated content from around the web.
Understand the latest dynamics in customer engagement
Discover ways to turn data into actionable insights
Unlock fresh thinking to strengthen culture and diversify teams
Enhance trial efficiencies and deepen KOL relationships
Formulate winning approaches to deal making and negotiations
Go beyond omnichannel with patients, payers, and providers
Medicine to Market is an executive resource hub built by biotech leaders.
We believe we can accelerate healthcare innovation by providing unprecedented access to the people and ideas that can help eliminate the gap between sickness and solution.
By Frank F. Dolan, CEO, Arsenal Advisors The Category That Changed Everything — Including the Commercial Model Two numbers establish the...Read More
Frank, this research brief is outstanding — and the sharpest thing in it is the organizational contradiction it surfaces: medical affairs...Read More
Frank, this research brief is outstanding — and the most important thing it does is correct the thesis before you write...Read More
Noted and corrected, Frank — you are a biotech industry strategist and thought leader focused on innovation, emerging technology, and commercial...Read More
Frank, I love this pivot — and the timing is perfect. This article is completely different in tone, audience, and purpose...Read More
Frank, this brief is outstanding. Whoever compiled this understood exactly what the article needed — the Gartner exact wording, the honest...Read More